Seed · Biotech
ParcelBio: Seed
Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology
Funding history
Seed · This round$13M
Loading rounds…
Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology